Clinical meaning
Osteogenesis imperfecta (OI), commonly known as brittle bone disease, is a group of genetic connective tissue disorders caused by defects in the synthesis, structure, or processing of type I collagen. Type I collagen is the most abundant protein in the human body and is a major structural component of bone, skin, tendons, ligaments, sclera of the eyes, dentin of the teeth, and blood vessel walls. Because type I collagen is so widely distributed, OI affects multiple organ systems, although its most prominent clinical feature is bone fragility with recurrent fractures. The molecular basis of OI involves mutations in one of several genes, most commonly COL1A1 and COL1A2, which encode the alpha-1 and alpha-2 chains of type I procollagen, respectively. These mutations produce either quantitatively deficient collagen (less collagen of normal quality) or qualitatively abnormal collagen (normal amounts of structurally defective collagen). The Sillence classification system divides OI into four main types based on clinical severity. Type I (mild, most common, accounting for approximately 50 percent of cases) produces collagen of normal quality but in reduced quantity; patients have blue sclera, mild to moderate bone fragility, and normal or near-normal stature. Type II (perinatal lethal) is the most severe form; multiple fractures occur in utero, and most affected infants die during the neonatal period from respiratory failure due to a small, malformed thoracic cage. Type III (progressively deforming) causes severe bone fragility with hundreds of fractures throughout life, progressive skeletal deformity, very short stature, triangular facies, and severe scoliosis; sclera may be blue at birth but often become white with age. Type IV (moderately severe) presents with moderate bone fragility, variable short stature, and normal or slightly blue sclera. The pathogenesis of bone fragility in OI relates directly to the role of type I collagen in bone formation. Bone is composed of an organic matrix (primarily type I collagen fibers that provide tensile strength and flexibility) and an inorganic mineral phase (hydroxyapatite crystals that provide compressive strength and rigidity). In OI, defective collagen produces a disorganized organic matrix that cannot properly support mineralization, resulting in bones that are thin, porous, and structurally weak. The bones fracture easily, often from minimal or no apparent trauma, which is a distinguishing clinical feature. Blue sclera, one of the hallmark findings in OI Type I, occurs because the thin, defective collagen in the sclera allows the underlying choroidal vasculature to show through, producing a characteristic blue-gray appearance. Dentinogenesis imperfecta (opalescent, discolored teeth prone to cracking and wearing) occurs because type I collagen is also a major component of dentin. Hearing loss develops in approximately 50 percent of adults with OI, caused by otosclerosis (abnormal bone remodeling in the middle ear ossicles). Joint hypermobility, thin translucent skin with easy bruising, and short stature are additional findings related to the widespread collagen deficiency. The practical nurse must understand that OI patients require exceptionally gentle handling during all care activities. Fractures can occur during routine activities such as diaper changing in infants, repositioning, blood pressure cuff inflation, or physical therapy. Non-accidental injury (child abuse) must be carefully distinguished from OI in children presenting with multiple fractures, making accurate genetic diagnosis essential.